Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

Overview of attention for article published in Cancer Immunology, Immunotherapy, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter: 2 X users

patent: 8 patents

Citations

dimensions_citation: 159 Dimensions

Readers on

mendeley: 318 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Method for detecting effector regulatory T cells, analyzer for effector regulatory T cells…

Grant JP-7128480-B2

Japan

Treatment of cancer with anti-LAP monoclonal antibodies

Grant US-11407823-B2

United States of America

Methods of using anti-lap antibodies

Grant US-11230601-B2

United States of America

Anti-lap antibody variants

Grant US-11130802-B2

United States of America

EFFECTOR TYPE REGULATORY T CELL DETECTING METHOD, EFFECTOR TYPE REGULATORY T CELL…

Application EP-3611504-A4

European Patent Office

Effector-type regulatory T cell detection method, effector-type regulatory T cell analyzer…

Application JP-WO2018190340-A1

Japan

SIZE-BASED GATING TO ANALYZE FLOW CYTOMETRY DATA

Application WO-2020058308-A1

World Intellectual Property Organisation (WIPO)

Treatment of cancer with anti-lap monoclonal antibodies

Grant US-10287347-B2

United States of America